Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome

Bonanni A.;Calatroni M.;D'Alessandro M;Signa S.;Bertelli E.;Cioni M.;Di Marco E.;Biassoni R.;Caridi G.;Ingrasciotta G.;Bertelli R.;Di Donato A.;Bruschi M.;Canepa A.;Piaggio G.;Ravani P.;Ghiggeri G. M.

2018-01-01